MUSC Announces Retirement of President David J. Cole, Recognizing a Legacy of Transformative Leadership and Service

Announcement begins year-long transition process and national search ahead of June 2027 retirement.

Charleston, S.C. (June 29, 2026) – The Medical University of South Carolina (MUSC) announced today that David J. Cole, M.D., FACS, will retire in June of 2027, after what will be 13 successful years as MUSC’s seventh president.

Since 2014, Cole has led MUSC through rapid transformation and strategic growth. The organization now delivers care in all 46 counties across South Carolina. Working across the enterprise, and with leaders across the state and beyond, Cole has been a trailblazer for healthcare, research and education.

“It is impossible to overstate the impact of Dr. Cole’s leadership on MUSC. His bold vision and unwavering dedication have left an indelible mark on students, faculty, researchers and staff,” said Charles W. Schulze, CPA, Chairman of the MUSC and MUHA Board of Trustees.

During his term, MUSC expanded statewide and global partnerships, rural care and telehealth connectivity, and secured record research funding. Cole, along with enterprise leaders and key stakeholders, secured support for the construction and opening of Shawn Jenkins Children’s Hospital and Pearl Tourville Women’s Pavilion, as well as the Jean and Hugh K. Leatherman Behavioral Care Pavilion in Florence.

For 11 years running, U.S. News & World Report has ranked MUSC as the “Best Hospital” in South Carolina.

Cole, who joined MUSC in 1994, will remain part of MUSC’s family as a professor and surgical oncologist, providing the MUSC community with invaluable experience and delivering lifesaving expertise to patients.

“MUSC is, without doubt, a jewel in South Carolina’s crown,” Cole said. “To have had the opportunity to lead and serve this remarkable institution has been one of the great privileges of my life. MUSC stands today as one of the nation’s leading academic medical centers, a testament to what can be achieved when people are united in service to patients, students, families, communities and one another.

“I am deeply thankful to the many people who supported me, but I am especially grateful to my wife, Kathy, whose steadfast support, generosity of spirit and tireless commitment to myself and the MUSC community have meant more than I can adequately express,” Cole said.

The MUSC Board of Trustees will begin an extensive nationwide search for Cole’s successor, led by former Board chairman and sitting trustee James Lemon, D.M.D. The search process is expected to conclude next spring.

                                                                                       ###

About MUSC 

Founded in 1824 in Charleston, MUSC is the state’s only comprehensive academic health system, with a mission to preserve and optimize human life in South Carolina through education, research and patient care. Each year, MUSC educates nearly 3,500 students in six colleges and trains more than 1,060 residents and fellows across its health system. MUSC leads the state in federal, National Institutes of Health and other research funding. For information on our academic programs, visit musc.edu.

As the healthcare system of the Medical University of South Carolina, MUSC Health is dedicated to delivering the highest-quality and safest patient care while educating and training generations of outstanding healthcare providers and leaders to serve the people of South Carolina and beyond. In 2025, for the 11th consecutive year, U.S. News & World Report named MUSC Health University Medical Center in Charleston the No. 1 hospital in South Carolina. To learn more about clinical patient services, visit muschealth.org.

MUSC has a total enterprise annual operating budget of $8.9 billion. The more than 36,200 MUSC members include world-class faculty, physicians, specialty providers, scientists, contract employees, affiliates and care team members who deliver groundbreaking education, research and patient care.

Join now to enjoy expanded member benefits!

Enjoy exclusive member content, special events, savings, networking and more

Paige Durham

SCbio is pleased to welcome Paige Durham to the team as communications coordinator to creatively and effectively communicate the value of the life science association’s programs and initiatives.

Durham will be responsible for developing and distributing high-quality content across multiple communications channels to build, advance and grow South Carolina’s life sciences industry, a key business sector for economic prosperity for the Palmetto State.

“SCbio is excited to welcome Paige to our team as our new communications coordinator. Paige brings fresh ideas and a strong background in communications that will be invaluable as we continue to strengthen our engagement with our audience,” said SCbio President and CEO James Chappell. “We are confident that her skills and experience will be crucial in advancing our communication strategies and supporting our mission.”

Before joining SCbio, Durham was the Membership and Communications Manager at the South Carolina Pharmacy Association (SCPhA), where she used her photography, design and writing skills to create content tailored to pharmacy professionals. Durham’s effective communication skills guaranteed the delivery of brand-specific material that captured the eye of her audience.

During her time at SCPhA, Durham created and edited the Palmetto Pharmacist Journal, using her creative vision to showcase members, educational institutions and industry news. Her communications efforts successfully gained new followers for the organization over the course of a year, increasing brand visibility and promoting the pharmacy profession.

Durham holds a Bachelor of Science in hospitality and tourism management and a Bachelor of Science in business administration from the College of Charleston.

Tamia Sumpter

Tamia is a driven senior undergraduate Bioengineering student currently enrolled at Clemson University. With a strong foundation in her field, she has honed her skills through hands-on experience in research and development at Eli Lilly & Company. During her time in the ADME department, Tamia contributed significantly by working on siRNAs and their applications in finding In Vitro-In Vivo Correlation (IVIVC). Looking ahead, Tamia has set her sights on a promising career in law. She aspires to specialize in Intellectual Property Law, with a particular focus on serving as in-house counsel for leading medical device or pharmaceutical companies. Her enthusiasm for this role is palpable as she prepares to embark on her legal journey! She is also a proud member of the Omicron Phi chapter of Delta Sigma Theta Sorority, Inc., PEER Mentor for Clemson PEER/WiSE, and currently serves as the President of Clemson Bioengineering Organization (CBO). With her unique blend of scientific knowledge and legal interests, Tamia is poised to make a meaningful impact in the healthcare and life sciences industries.